nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—Appetite absent—Metformin—polycystic ovary syndrome	0.0187	0.0693	CcSEcCtD
Guanabenz—CYP1A2—urine—polycystic ovary syndrome	0.0185	0.121	CbGeAlD
Guanabenz—Nail disorder—Metformin—polycystic ovary syndrome	0.0143	0.0532	CcSEcCtD
Guanabenz—NISCH—adrenal cortex—polycystic ovary syndrome	0.0124	0.0809	CbGeAlD
Guanabenz—Accidental injury—Metformin—polycystic ovary syndrome	0.0105	0.039	CcSEcCtD
Guanabenz—NISCH—uterus—polycystic ovary syndrome	0.0102	0.0666	CbGeAlD
Guanabenz—NISCH—pituitary gland—polycystic ovary syndrome	0.01	0.0654	CbGeAlD
Guanabenz—NISCH—adipose tissue—polycystic ovary syndrome	0.00997	0.0651	CbGeAlD
Guanabenz—NISCH—adrenal gland—polycystic ovary syndrome	0.00894	0.0584	CbGeAlD
Guanabenz—NISCH—female gonad—polycystic ovary syndrome	0.00834	0.0545	CbGeAlD
Guanabenz—NISCH—vagina—polycystic ovary syndrome	0.00829	0.0541	CbGeAlD
Guanabenz—Injury—Metformin—polycystic ovary syndrome	0.00733	0.0272	CcSEcCtD
Guanabenz—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.0069	0.0257	CcSEcCtD
Guanabenz—Dehydration—Metformin—polycystic ovary syndrome	0.00627	0.0233	CcSEcCtD
Guanabenz—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00622	0.0231	CcSEcCtD
Guanabenz—Breast disorder—Metformin—polycystic ovary syndrome	0.00609	0.0226	CcSEcCtD
Guanabenz—Cramp muscle—Metformin—polycystic ovary syndrome	0.00607	0.0225	CcSEcCtD
Guanabenz—Abdominal distension—Metformin—polycystic ovary syndrome	0.00586	0.0218	CcSEcCtD
Guanabenz—Influenza—Metformin—polycystic ovary syndrome	0.00582	0.0216	CcSEcCtD
Guanabenz—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.00566	0.037	CbGeAlD
Guanabenz—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00558	0.0207	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00541	0.0201	CcSEcCtD
Guanabenz—Infestation NOS—Metformin—polycystic ovary syndrome	0.00519	0.0193	CcSEcCtD
Guanabenz—Infestation—Metformin—polycystic ovary syndrome	0.00519	0.0193	CcSEcCtD
Guanabenz—ADRA2C—endometrium—polycystic ovary syndrome	0.00505	0.033	CbGeAlD
Guanabenz—ADRA2C—uterus—polycystic ovary syndrome	0.00466	0.0304	CbGeAlD
Guanabenz—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00459	0.0171	CcSEcCtD
Guanabenz—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00458	0.017	CcSEcCtD
Guanabenz—ADRA2C—pituitary gland—polycystic ovary syndrome	0.00457	0.0299	CbGeAlD
Guanabenz—ADRA2C—adipose tissue—polycystic ovary syndrome	0.00455	0.0297	CbGeAlD
Guanabenz—Eye disorder—Metformin—polycystic ovary syndrome	0.00436	0.0162	CcSEcCtD
Guanabenz—Immune system disorder—Metformin—polycystic ovary syndrome	0.00421	0.0156	CcSEcCtD
Guanabenz—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0042	0.0156	CcSEcCtD
Guanabenz—Chills—Metformin—polycystic ovary syndrome	0.00418	0.0155	CcSEcCtD
Guanabenz—ADRA2C—adrenal gland—polycystic ovary syndrome	0.00408	0.0267	CbGeAlD
Guanabenz—Erythema—Metformin—polycystic ovary syndrome	0.00406	0.0151	CcSEcCtD
Guanabenz—Malnutrition—Metformin—polycystic ovary syndrome	0.00406	0.0151	CcSEcCtD
Guanabenz—ADRA2A—endometrium—polycystic ovary syndrome	0.00403	0.0263	CbGeAlD
Guanabenz—Flatulence—Metformin—polycystic ovary syndrome	0.004	0.0149	CcSEcCtD
Guanabenz—Muscle spasms—Metformin—polycystic ovary syndrome	0.0039	0.0145	CcSEcCtD
Guanabenz—Vision blurred—Metformin—polycystic ovary syndrome	0.00382	0.0142	CcSEcCtD
Guanabenz—ADRA2C—female gonad—polycystic ovary syndrome	0.00381	0.0249	CbGeAlD
Guanabenz—ADRA2C—vagina—polycystic ovary syndrome	0.00379	0.0247	CbGeAlD
Guanabenz—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00376	0.014	CcSEcCtD
Guanabenz—ADRA2A—uterus—polycystic ovary syndrome	0.00371	0.0243	CbGeAlD
Guanabenz—Malaise—Metformin—polycystic ovary syndrome	0.00366	0.0136	CcSEcCtD
Guanabenz—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00365	0.0238	CbGeAlD
Guanabenz—Syncope—Metformin—polycystic ovary syndrome	0.00364	0.0135	CcSEcCtD
Guanabenz—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00363	0.0237	CbGeAlD
Guanabenz—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00357	0.0133	CcSEcCtD
Guanabenz—Hypertension—Metformin—polycystic ovary syndrome	0.0035	0.013	CcSEcCtD
Guanabenz—Myalgia—Metformin—polycystic ovary syndrome	0.00345	0.0128	CcSEcCtD
Guanabenz—Chest pain—Metformin—polycystic ovary syndrome	0.00345	0.0128	CcSEcCtD
Guanabenz—Discomfort—Metformin—polycystic ovary syndrome	0.00341	0.0127	CcSEcCtD
Guanabenz—Oedema—Metformin—polycystic ovary syndrome	0.00331	0.0123	CcSEcCtD
Guanabenz—Infection—Metformin—polycystic ovary syndrome	0.00329	0.0122	CcSEcCtD
Guanabenz—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00326	0.0213	CbGeAlD
Guanabenz—Shock—Metformin—polycystic ovary syndrome	0.00326	0.0121	CcSEcCtD
Guanabenz—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00325	0.0121	CcSEcCtD
Guanabenz—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00324	0.012	CcSEcCtD
Guanabenz—Skin disorder—Metformin—polycystic ovary syndrome	0.00322	0.012	CcSEcCtD
Guanabenz—Anorexia—Metformin—polycystic ovary syndrome	0.00316	0.0117	CcSEcCtD
Guanabenz—Hypotension—Metformin—polycystic ovary syndrome	0.00309	0.0115	CcSEcCtD
Guanabenz—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00307	0.0201	CbGeAlD
Guanabenz—ADRA2A—female gonad—polycystic ovary syndrome	0.00304	0.0199	CbGeAlD
Guanabenz—ADRA2A—vagina—polycystic ovary syndrome	0.00302	0.0197	CbGeAlD
Guanabenz—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00302	0.0112	CcSEcCtD
Guanabenz—Paraesthesia—Metformin—polycystic ovary syndrome	0.00297	0.0111	CcSEcCtD
Guanabenz—Dyspnoea—Metformin—polycystic ovary syndrome	0.00295	0.011	CcSEcCtD
Guanabenz—Dyspepsia—Metformin—polycystic ovary syndrome	0.00291	0.0108	CcSEcCtD
Guanabenz—Decreased appetite—Metformin—polycystic ovary syndrome	0.00288	0.0107	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00286	0.0106	CcSEcCtD
Guanabenz—Fatigue—Metformin—polycystic ovary syndrome	0.00285	0.0106	CcSEcCtD
Guanabenz—Constipation—Metformin—polycystic ovary syndrome	0.00283	0.0105	CcSEcCtD
Guanabenz—ADRA2A—endocrine gland—polycystic ovary syndrome	0.00283	0.0185	CbGeAlD
Guanabenz—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00273	0.0101	CcSEcCtD
Guanabenz—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00271	0.0101	CcSEcCtD
Guanabenz—Urticaria—Metformin—polycystic ovary syndrome	0.00263	0.00978	CcSEcCtD
Guanabenz—Abdominal pain—Metformin—polycystic ovary syndrome	0.00262	0.00973	CcSEcCtD
Guanabenz—Asthenia—Metformin—polycystic ovary syndrome	0.00238	0.00883	CcSEcCtD
Guanabenz—Pruritus—Metformin—polycystic ovary syndrome	0.00234	0.00871	CcSEcCtD
Guanabenz—Diarrhoea—Metformin—polycystic ovary syndrome	0.00227	0.00842	CcSEcCtD
Guanabenz—Dizziness—Metformin—polycystic ovary syndrome	0.00219	0.00814	CcSEcCtD
Guanabenz—Vomiting—Metformin—polycystic ovary syndrome	0.00211	0.00782	CcSEcCtD
Guanabenz—Rash—Metformin—polycystic ovary syndrome	0.00209	0.00776	CcSEcCtD
Guanabenz—Dermatitis—Metformin—polycystic ovary syndrome	0.00209	0.00775	CcSEcCtD
Guanabenz—Headache—Metformin—polycystic ovary syndrome	0.00207	0.00771	CcSEcCtD
Guanabenz—Nausea—Metformin—polycystic ovary syndrome	0.00197	0.00731	CcSEcCtD
Guanabenz—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000195	0.000337	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000194	0.000336	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—LHB—polycystic ovary syndrome	0.000194	0.000336	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000193	0.000335	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000191	0.00033	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—HSD3B2—polycystic ovary syndrome	0.00019	0.000328	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000188	0.000325	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000188	0.000325	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000187	0.000324	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000187	0.000324	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000186	0.000323	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000185	0.00032	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKR1C1—polycystic ovary syndrome	0.000184	0.000318	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000183	0.000316	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000183	0.000316	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000183	0.000316	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000181	0.000314	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	0.000181	0.000313	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000178	0.000308	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	0.000178	0.000308	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000177	0.000306	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000176	0.000304	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000175	0.000303	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000174	0.000301	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000174	0.0003	CbGpPWpGaD
Guanabenz—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000173	0.0003	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	0.000173	0.000299	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00017	0.000295	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00017	0.000294	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00017	0.000294	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SULT2A1—polycystic ovary syndrome	0.000169	0.000292	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	0.000168	0.000291	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	0.000168	0.000291	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000166	0.000288	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000166	0.000288	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000165	0.000286	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000164	0.000284	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000164	0.000284	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000164	0.000284	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—RRM2—polycystic ovary syndrome	0.000164	0.000283	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000163	0.000282	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000162	0.000281	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000162	0.000281	CbGpPWpGaD
Guanabenz—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000162	0.00028	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000161	0.000278	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00016	0.000276	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000159	0.000275	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000159	0.000274	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—YAP1—polycystic ovary syndrome	0.000158	0.000273	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	0.000158	0.000273	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—IGF1—polycystic ovary syndrome	0.000157	0.000272	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—AKT2—polycystic ovary syndrome	0.000157	0.000271	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000155	0.000269	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000154	0.000266	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000154	0.000266	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000153	0.000265	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000153	0.000264	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000152	0.000263	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NAMPT—polycystic ovary syndrome	0.000152	0.000262	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000151	0.000262	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000151	0.000262	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000151	0.000261	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00015	0.00026	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP11A1—polycystic ovary syndrome	0.00015	0.000259	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000149	0.000258	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000149	0.000258	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000149	0.000258	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000148	0.000257	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000148	0.000256	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000148	0.000256	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000147	0.000255	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000145	0.000251	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000142	0.000247	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000142	0.000246	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000142	0.000246	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	0.000141	0.000245	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000141	0.000244	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000141	0.000244	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.00014	0.000242	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000139	0.000241	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	0.000139	0.000241	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000139	0.000241	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000138	0.00024	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000137	0.000237	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000135	0.000234	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000134	0.000232	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000133	0.000231	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000133	0.00023	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	0.000133	0.00023	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000132	0.000228	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000132	0.000228	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00013	0.000225	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000129	0.000223	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	0.000128	0.000222	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	0.000128	0.000221	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	0.000127	0.000221	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000127	0.000219	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000125	0.000216	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000125	0.000216	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000124	0.000215	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000124	0.000215	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000124	0.000215	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000123	0.000214	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	0.000123	0.000213	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000122	0.000211	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000122	0.00021	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000121	0.00021	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—TH—polycystic ovary syndrome	0.00012	0.000208	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000118	0.000205	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000118	0.000204	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000118	0.000203	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	0.000117	0.000203	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000116	0.000201	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000116	0.0002	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000115	0.000199	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000115	0.000199	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000115	0.000199	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000115	0.000198	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000115	0.000198	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000113	0.000196	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000113	0.000196	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000112	0.000194	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000111	0.000192	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00011	0.000191	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	0.00011	0.000191	CbGpPWpGaD
Guanabenz—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	0.00011	0.00019	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000109	0.000189	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000107	0.000185	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000107	0.000185	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000107	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000107	0.000185	CbGpPWpGaD
Guanabenz—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000106	0.000184	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000106	0.000183	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000103	0.000179	CbGpPWpGaD
Guanabenz—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	0.000103	0.000177	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000102	0.000177	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000101	0.000175	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000101	0.000175	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.0001	0.000174	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.0001	0.000173	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.0001	0.000173	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.96e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.91e-05	0.000172	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	9.83e-05	0.00017	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—TH—polycystic ovary syndrome	9.78e-05	0.000169	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.64e-05	0.000167	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.6e-05	0.000166	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.54e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	9.51e-05	0.000165	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.49e-05	0.000164	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.45e-05	0.000164	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	9.43e-05	0.000163	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.43e-05	0.000163	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	9.37e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	9.36e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	9.35e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	9.34e-05	0.000162	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	9e-05	0.000156	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	8.94e-05	0.000155	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.94e-05	0.000155	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	8.88e-05	0.000154	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.86e-05	0.000153	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	8.8e-05	0.000152	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	8.7e-05	0.00015	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	8.7e-05	0.00015	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.7e-05	0.00015	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.5e-05	0.000147	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.38e-05	0.000145	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.38e-05	0.000145	CbGpPWpGaD
Guanabenz—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	8.33e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.3e-05	0.000144	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	8.27e-05	0.000143	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	8.23e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	8.23e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	8.22e-05	0.000142	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.09e-05	0.00014	CbGpPWpGaD
Guanabenz—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.05e-05	0.000139	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	7.98e-05	0.000138	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.83e-05	0.000135	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	7.68e-05	0.000133	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	7.66e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	7.61e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	7.6e-05	0.000132	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	7.59e-05	0.000131	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.58e-05	0.000131	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	7.34e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.31e-05	0.000127	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	7.21e-05	0.000125	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.2e-05	0.000125	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	7.07e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	7.05e-05	0.000122	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	6.9e-05	0.000119	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.79e-05	0.000118	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.76e-05	0.000117	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	6.72e-05	0.000116	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.71e-05	0.000116	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	6.71e-05	0.000116	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	6.67e-05	0.000116	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.66e-05	0.000115	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	6.62e-05	0.000115	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	6.58e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2C—Metabolism—INS—polycystic ovary syndrome	6.58e-05	0.000114	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	6.44e-05	0.000111	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.36e-05	0.00011	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.34e-05	0.00011	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.24e-05	0.000108	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.24e-05	0.000108	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	6.15e-05	0.000106	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	5.92e-05	0.000103	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	5.89e-05	0.000102	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	5.75e-05	9.94e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.7e-05	9.86e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.69e-05	9.85e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	5.53e-05	9.58e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	5.5e-05	9.52e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	5.45e-05	9.43e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.41e-05	9.36e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.4e-05	9.34e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	5.37e-05	9.3e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.35e-05	9.25e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Metabolism—INS—polycystic ovary syndrome	5.35e-05	9.25e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	5.32e-05	9.21e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	5.32e-05	9.2e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.25e-05	9.09e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.23e-05	9.05e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.05e-05	8.75e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	4.94e-05	8.54e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.67e-05	8.08e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.49e-05	7.78e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	4.47e-05	7.73e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.41e-05	7.63e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.36e-05	7.54e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.32e-05	7.48e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.32e-05	7.48e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.2e-05	7.26e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.11e-05	7.1e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.07e-05	7.04e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	3.98e-05	6.89e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.72e-05	6.44e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.71e-05	6.42e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.48e-05	6.02e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.31e-05	5.72e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.01e-05	5.21e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.97e-05	5.13e-05	CbGpPWpGaD
Guanabenz—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.95e-05	5.11e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.82e-05	4.89e-05	CbGpPWpGaD
Guanabenz—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.57e-05	4.45e-05	CbGpPWpGaD
Guanabenz—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.4e-05	4.16e-05	CbGpPWpGaD
Guanabenz—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.95e-05	3.38e-05	CbGpPWpGaD
